Literature DB >> 27329816

Clinical characterization of influenza A and human respiratory syncytial virus among patients with influenza like illness.

Swati Saxena1,2, Dharamveer Singh1, Amreen Zia1, Jyoti Umrao1, Naveen Srivastava1, Ankita Pandey1, Sushma Singh1, Piyali Bhattacharya1, Reema Kumari2, Ramawadh Kushwaha2, T N Dhole3.   

Abstract

Influenza A and Respiratory Syncytial Virus (RSV) has been recognized as a major cause of acute respiratory tract infection. H1N1 is one of the subtypes of influenza A, pandemic worldwide in July 2009, causing 18,449 deaths globally. To investigate the prevalence and clinical manifestation of the influenza A, H1N1pdm09, and RSV. Throat/nasal swab collected from the patients of all age group either outpatients/inpatients having respiratory illness from 2 to 5 days. The clinical data were recorded in a predesigned questionnaire. RNA was extracted and analyzed by real time PCR at a tertiary care center, 2009-2014. Total 4,352 samples tested for influenza A and H1N1. Out of 4,352, 32.2% (median positivity 21%; range 16-41% during 6 years) were positive for influenza A and 19% were H1N1 (median positivity 16.7%; range 8.7-23% during 6 years). Total 1653 samples were analyzed for RSV from 2011 to 2014, 12% were RSV positive (median positivity 11.35%; range 10-16.3% during 4 years). Pharyngitis, dyspnea were frequent symptoms in influenza A and H1N1 (P < 0.005) whereas bronchiolitis and pneumonia were commonly present in RSV (P < 0.005). The positivity of influenza A and H1N1 was higher in age-group 21-30, whereas RSV in infant and children. H1N1 and RSV were co-circulated and have common clinical symptoms particularly in lower age group. Therefore, laboratory confirmation is necessary for further disease prognosis. Age was an important risk factor that affects the positivity of influenza A, H1N1, and RSV. Different clinical manifestation of H1N1 and RSV will be helpful for early and accurate diagnosis. J. Med. Virol. 89:49-54, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  epidemiology; influenza virus; respiratory tract infection

Mesh:

Substances:

Year:  2016        PMID: 27329816     DOI: 10.1002/jmv.24607

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Respiratory syncytial virus among children hospitalized with severe acute respiratory infection in Kashmir, a temperate region in northern India.

Authors:  Parvaiz A Koul; Siddhartha Saha; Kaisar A Kaul; Hyder Mir; Varsha Potdar; Mandeep Chadha; Danielle Iuliano; Kathryn E Lafond; Renu B Lal; Anand Krishnan
Journal:  J Glob Health       Date:  2022-07-16       Impact factor: 7.664

2.  Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.

Authors:  Elisa H Fleming; Eliana E Ochoa; Joan E Nichols; M Kerry O'Banion; Alan R Salkind; Norbert J Roberts
Journal:  J Med Virol       Date:  2017-09-26       Impact factor: 2.327

3.  Sequence Analysis of the Fusion Protein Gene of Human Respiratory Syncytial Virus Circulating in China from 2003 to 2014.

Authors:  Jinhua Song; Huiling Wang; Teresa I Ng; Aili Cui; Shuangli Zhu; Yanzhi Huang; Liwei Sun; Zifeng Yang; Deshan Yu; Pengbo Yu; Hong Zhang; Yan Zhang; Wenbo Xu
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

4.  Prevalence of respiratory syncytial virus infection among children hospitalized with acute lower respiratory tract infections in Southern India.

Authors:  Sandesh Kini; Bhuvanesh Sukhlal Kalal; Sara Chandy; Ranjani Shamsundar; Anita Shet
Journal:  World J Clin Pediatr       Date:  2019-04-09

5.  Delayed Diagnosis of Respiratory Syncytial Virus Infections in Hospitalized Adults: Individual Patient Data, Record Review Analysis and Physician Survey in the United States.

Authors:  Nelson Lee; Edward E Walsh; Ian Sander; Robert Stolper; Jessica Zakar; Veronique Wyffels; David Myers; Roman Fleischhackl
Journal:  J Infect Dis       Date:  2019-08-09       Impact factor: 5.226

6.  Evaluation of Seegene Allplex Respiratory Panel 1 kit for the detection of influenza virus and human respiratory syncytial virus.

Authors:  Laura Gimferrer; Cristina Andrés; Ariadna Rando; Maria Piñana; Maria Gema Codina; Maria Del Carmen Martin; Francisco Fuentes; Susana Rubio; Pilar Alcubilla; Tomàs Pumarola; Andrés Antón
Journal:  J Clin Virol       Date:  2018-05-25       Impact factor: 3.168

7.  Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012-2017).

Authors:  Hamad E Al-Romaihi; Maria K Smatti; Hebah A Al-Khatib; Peter V Coyle; Nandakumar Ganesan; Shazia Nadeem; Elmoubasher A Farag; Asmaa A Al Thani; Abdullatif Al Khal; Khalid M Al Ansari; Muna A Al Maslamani; Hadi M Yassine
Journal:  Int J Infect Dis       Date:  2020-04-09       Impact factor: 3.623

8.  The effects of age on clinical characteristics, hospitalization and mortality of patients with influenza-related illness at a tertiary care centre in Malaysia.

Authors:  Pui Li Wong; Hoe Leong Sii; Chun Keat P'ng; Soon Sean Ee; Xiang Yong Oong; Kim Tien Ng; Nik Sherina Hanafi; Kok Keng Tee; Maw Pin Tan
Journal:  Influenza Other Respir Viruses       Date:  2020-02-05       Impact factor: 4.380

9.  Influenza A Virus as a Predisposing Factor for Cryptococcosis.

Authors:  Lorena V N Oliveira; Marliete C Costa; Thaís F F Magalhães; Rafael W Bastos; Patrícia C Santos; Hellem C S Carneiro; Noelly Q Ribeiro; Gabriella F Ferreira; Lucas S Ribeiro; Ana P F Gonçalves; Caio T Fagundes; Marcelo A Pascoal-Xavier; Julianne T Djordjevic; Tania C Sorrell; Daniele G Souza; Alexandre M V Machado; Daniel A Santos
Journal:  Front Cell Infect Microbiol       Date:  2017-09-26       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.